These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25865181)

  • 1. Placebo non-response measure in sequential parallel comparison design studies.
    Rybin D; Doros G; Pencina MJ; Fava M
    Stat Med; 2015 Jul; 34(15):2281-93. PubMed ID: 25865181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies.
    Doros G; Pencina M; Rybin D; Meisner A; Fava M
    Stat Med; 2013 Jul; 32(16):2767-89. PubMed ID: 23355369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose finding with the sequential parallel comparison design.
    Wang JJ; Ivanova A
    J Biopharm Stat; 2014; 24(5):1091-101. PubMed ID: 24919070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-way enriched clinical trial design: combining advantages of placebo lead-in and randomized withdrawal.
    Ivanova A; Tamura RN
    Stat Methods Med Res; 2015 Dec; 24(6):871-90. PubMed ID: 22143405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can sequential parallel comparison design and two-way enriched design be useful in medical device clinical trials?
    Ivanova A; Zhang Z; Thompson L; Yang Y; Kotz RM; Fang X
    J Biopharm Stat; 2016; 26(1):167-77. PubMed ID: 26368863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of adaptive design variations on the sequential parallel comparison design for clinical trials.
    Mi MY; Betensky RA
    Clin Trials; 2013 Apr; 10(2):207-15. PubMed ID: 23283576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple test for the treatment effect in clinical trials with a sequential parallel comparison design and negative binomial outcomes.
    Homma G; Daimon T
    Pharm Stat; 2019 Mar; 18(2):184-197. PubMed ID: 30411482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size re-estimation and other midcourse adjustments with sequential parallel comparison design.
    Silverman RK; Ivanova A
    J Biopharm Stat; 2017; 27(3):416-425. PubMed ID: 28166457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimality, sample size, and power calculations for the sequential parallel comparison design.
    Ivanova A; Qaqish B; Schoenfeld DA
    Stat Med; 2011 Oct; 30(23):2793-803. PubMed ID: 21805484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of novel methods in two-way enriched clinical trial design.
    Liu Y; Rybin D; Heeren TC; Doros G
    Stat Med; 2019 Sep; 38(21):4112-4130. PubMed ID: 31256435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential parallel comparison design with binary and time-to-event outcomes.
    Silverman RK; Ivanova A; Fine J
    Stat Med; 2018 Apr; 37(9):1454-1466. PubMed ID: 29462838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN; Huang X
    Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials.
    Chen YF; Yang Y; Hung HM; Wang SJ
    Contemp Clin Trials; 2011 Jul; 32(4):592-604. PubMed ID: 21540126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential parallel comparison design with two coprimary endpoints.
    Homma G; Daimon T
    Pharm Stat; 2020 May; 19(3):243-254. PubMed ID: 31829521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Power calculations for the sequential parallel comparison design with continuous outcomes.
    Ivanova A; Qaqish B
    J Biopharm Stat; 2020 Nov; 30(6):1121-1129. PubMed ID: 32991233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomization-based analysis of covariance for inference in the sequential parallel comparison design.
    Wiener LE; Ivanova A; Li S; Silverman RK; Koch GG
    J Biopharm Stat; 2019; 29(4):696-713. PubMed ID: 31304861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The network meta-analytic-predictive approach to non-inferiority trials.
    Schmidli H; Wandel S; Neuenschwander B
    Stat Methods Med Res; 2013 Apr; 22(2):219-40. PubMed ID: 22218367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exact and asymptotic tests under the sequential parallel comparison design.
    Lui KJ
    Pharm Stat; 2018 Nov; 17(6):835-845. PubMed ID: 30141237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sequential enriched design for target patient population in psychiatric clinical trials.
    Chen YF; Zhang X; Tamura RN; Chen CM
    Stat Med; 2014 Jul; 33(17):2953-67. PubMed ID: 25927082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison design.
    Liu X; Kim C; Han Z; Lim P; Roychoudhury S; Fava M; Doros G
    Stat Med; 2022 May; 41(12):2166-2190. PubMed ID: 35184326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.